Intrepid Financial Planning Group LLC Acumen Pharmaceuticals, Inc. Transaction History
Intrepid Financial Planning Group LLC
- $232 Million
- Q3 2024
A detailed history of Intrepid Financial Planning Group LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 30,150 shares of ABOS stock, worth $55,777. This represents 0.03% of its overall portfolio holdings.
Number of Shares
30,150
Previous 30,150
-0.0%
Holding current value
$55,777
Previous $72,000
2.78%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ABOS
# of Institutions
78Shares Held
41.8MCall Options Held
57.7KPut Options Held
749K-
Ra Capital Management, L.P. Boston, MA14.9MShares$27.6 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$6.57 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.32 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$4.26 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.99 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $74.9M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...